Aetna Inc. now has permission from the Centers for Medicare and Medicaid Services (CMS) to resume selling Medicare plans.
CMS suspended the ability of Aetna, Hartford (NYSE:AET), to sell new Medicare Advantage and Medicare Part D prescription drug coverage in April 2010 because of concerns about Aetna's switch to a closed Medicare Part D "formulary," or covered drugs list, from an open formulary.
Aetna will resume marketing Medicare Advantage and drug plan products immediately, the company says. The company can enroll beneficiaries with effective dates beginning July 1.
Recommended For You
Even while the ban on new sales was in place, Aetna has been continuing to provide Medicare Advantage and Medicare drug plan coverage for about 1 million people.
The company provides or administers all types of health coverage for about 18 million people.
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Allison Bell
Allison Bell, a senior reporter at ThinkAdvisor and BenefitsPRO, previously was an associate editor at National Underwriter Life & Health. She has a bachelor's degree in economics from Washington University in St. Louis and a master's degree in journalism from the Medill School of Journalism at Northwestern University. She can be reached through X at @Think_Allison.
